Active Ingredient History
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Encephalitis, Japanese (approved 2009)
Chickenpox (Phase 3)
Communicable Diseases (Phase 2)
Dengue (Phase 2)
Dengue Virus (Phase 2)
Encephalitis (Phase 3)
Encephalitis, Japanese (Phase 4)
Healthy Volunteers (Phase 4)
Hepatitis A (Phase 3)
Immune System Diseases (Phase 4)
Japanese Encephalitis Vaccines (Phase 4)
Measles (Phase 4)
Meninges (Phase 3)
Meningitis, Meningococcal (Phase 3)
Meningococcal Infections (Phase 3)
Mumps (Phase 4)
Pre-Exposure Prophylaxis (Phase 2)
Rabies (Phase 3)
Rubella (Phase 4)
Severe Dengue (Phase 2)
Typhoid Fever (Phase 3)
Vaccine-Preventable Diseases (Phase 4)
Vaccines (Phase 4)
Virus Diseases (Phase 2)
Yellow Fever (Phase 3)
Zika Virus Infection (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue